Timeline
Avacta settles £3.67m convertible bond payment in cash
FDA clears single pivotal trial path for Avacta's AVA6000 in salivary gland cancer
Avacta starts dosing patients in AVA6103 trial with cash runway extended to early 2027
Avacta Group raises £9m to repay debt
Health & Bio Today: Avacta reports positive salivary gland cancer data, hVIVO, ValiRx, CRISM Therapeutics, ProBiotix Health
Avacta reports positive results in salivary gland cancer research
Health & Bio Today: CelLBxHealth wins AstraZeneca services deal, Avacta Group, AstraZeneca
Avacta names Richard Hughes as non‑executive chairman
Avacta says pre|CISION releases payload faster and more selectively than approved ADCs
Avacta demonstrates AVA6103 outdelivers Enhertu and reveals dual‑payload in vivo data
Avacta to raise c.£10m via equity placing
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.